We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MYLAN TO ACQUIRE KING IN $4 BILLION STOCK SWAP
MYLAN TO ACQUIRE KING IN $4 BILLION STOCK SWAP
July 27, 2004
Mylan Laboratories plans to acquire King Pharmaceuticals in a $4 billion stock swap that will give Mylan access to four of King’s brand drugs, which generate sales more than $100 million each.